Cargando…
State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us
The menopause is a midlife endocrinological process that greatly affects women’s central nervous system functions. Over the last 2 decades numerous clinical studies have addressed the influence of ovarian hormone decline on neurological disorders like Parkinson’s disease and Alzheimer’s disease. How...
Autores principales: | Unda, Santiago R., Marciano, Sabina, Milner, Teresa A., Marongiu, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631815/ https://www.ncbi.nlm.nih.gov/pubmed/36337706 http://dx.doi.org/10.3389/fnagi.2022.971007 |
Ejemplares similares
-
What artifice can and cannot tell us about animal behavior
por: Powell, Daniel L., et al.
Publicado: (2017) -
The demons of science: what they can and cannot tell us about our world
por: Weinert, Friedel
Publicado: (2016) -
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
por: Nerattini, Matilde, et al.
Publicado: (2023) -
Hypomimia in Parkinson's Disease: What Is It Telling Us?
por: Maycas-Cepeda, Teresa, et al.
Publicado: (2021) -
Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study
por: Yuk, Jin-Sung, et al.
Publicado: (2023)